SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HBOC...Buy in here? -- Ignore unavailable to you. Want to Upgrade?

To: dougjn who wrote (175)7/23/1998 6:23:00 PM
From: dr. z  Read Replies (2) | Respond to of 341
 
i think analysts are concerned that hboc's earnings growth is starting to slow and inmt as a company has not ben managed as well as hboc; this tends to add a lot of uncertainty until hboc can prove that this purchase is accretive to earnings.



To: dougjn who wrote (175)7/23/1998 7:37:00 PM
From: RAJU GEORGE  Respond to of 341
 
Last earning report HBOC SALES grew mostly on a product purchased from IMNT and sold under a label.If so, dont understand why this drop since HBOC could get it on cost price after they own it.
IMNT made profit last qtr and these profits came from selling their products to HBOC.
And after merger all profits will be under one umbrella.Right or wrong?



To: dougjn who wrote (175)7/24/1998 5:22:00 PM
From: Olu Emuleomo  Respond to of 341
 
This reaction to this small acquisition makes no sense.

I hear you! I dont know why investors are dumping this stock. But I really dont want to know. I cant ignore what the market is saying. (HBOC was $38, 2 weeks ago!)
All i know is that I am now sitting on a LOSS. I have sold 1/2 my position. I hope to sell the rest very close to $30. I've had enough!

--Olu E.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News